Skip to main content

NSTK News

TheStreet.com Rates 37 New ETFs

Two Vanguard bond funds receive top marks. Two HealthShares funds don't.

Feuerstein's Biotech-Stock Mailbag

Glaxo may face a tough sell with newly approved Treximet; additional feedback on Elan, and more.

Tuesday's Health Winners & Losers

Isis continues to climb after announcing a Genzyme partnership.

Biotech Notebook: Genitope, Amicus

Failing a phase III trial is never a good thing. Don't believe a CEO's attempt to spin it otherwise.

Biotech Notebook: Nastech, Amgen, PDL BioPharma

Skeptics of Nastech's nasal spray have gotten their due.

Breaking News

I Used Royal Caribbean's Starlink Internet (And Here's What I Think)

As someone who works a lot on cruise ships, I put Royal Caribbean's new internet to the test.

Bed Bath & Beyond Closes an Entire Chain as Bankruptcy Looms

The troubled retailer has taken another major step to try to stave off closure.

General Motors Stock Surges As Earnings Blast Street Forecasts; Sees Robust 2023 Profits

GM blasted Street profit forecasts with adjusted earnings of $2.12 per share on revenues of $43.1 billion.

Stock Market Today: Stocks Higher Amid Earnings Wave With Fed In Focus; IMF Boosts Global Growth Forecast

Wall Street is set to extend the S&P 500's solid January gains Tuesday as investors sort through a wave of corporate earnings ahead of tomorrow's crucial Fed rate decision.